CGON — CG Oncology Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapNeutral

Annual balance sheet for CG Oncology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	53.6	143	188	742	742
Net Total Accounts Receivable
Net Total Receivables	0.002	0.303	0.092	0.781	0.688
Total Inventory
Prepaid Expenses
Total Current Assets	58.4	147	194	754	759
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.2	0.506	0.491	0.493	19.6
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	58.7	148	199	755	792
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	5.97	15.4	14.3	21.4	30.8
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	18.4	22.6	14.5	21.4	39
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	40.3	125	185	733	753
Total Liabilities & Shareholders' Equity	58.7	148	199	755	792
Total Common Shares Outstanding